ASPN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aspen Aerogels Inc (ASPN) is not a strong buy for a beginner, long-term investor at this time. While the stock has shown some positive momentum in the short term, the lack of strong financial performance data, insider selling, and mixed analyst ratings suggest caution. The absence of recent news or significant positive catalysts further supports a hold recommendation.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating a positive short-term trend. However, the MACD is below 0 and negatively contracting, signaling weakening momentum. RSI is neutral at 68.232, and the stock is trading near its resistance level of 6.264, which may limit immediate upside potential.
The company has shown confidence in its European thermal barrier momentum, and there is a 60% chance of a 5.3% increase in the next month based on candlestick pattern analysis.
Insider selling has increased significantly (288.04% over the last month), and hedge funds remain neutral. Analyst ratings are mixed, with one firm maintaining an Underweight rating and highlighting disappointing Q1 results. Broader policy dynamics and demand reset for a key customer (GM) add uncertainty.
No financial data provided for the latest quarter. The company's Q1 results were described as 'modestly disappointing,' with EBITDA below consensus.
Barclays raised the price target to $4 from $3 but maintained an Underweight rating. Roth Capital raised the price target to $5.75 from $3 and maintained a Buy rating, citing long-term platform value but challenging near-term visibility.
